Literature DB >> 18467597

Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma.

Tomonori Hidaka1, Shingo Nakahata, Kinta Hatakeyama, Makoto Hamasaki, Kiyoshi Yamashita, Takashi Kohno, Yasuhito Arai, Tomohiko Taki, Kazuhiro Nishida, Akihiko Okayama, Yujiro Asada, Ryoji Yamaguchi, Hirohito Tsubouchi, Jun Yokota, Masafumi Taniwaki, Yujiro Higashi, Kazuhiro Morishita.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is caused by latent human T-lymphotropic virus-1 (HTLV-1) infection. To clarify the molecular mechanism underlying leukemogenesis after viral infection, we precisely mapped 605 chromosomal breakpoints in 61 ATLL cases by spectral karyotyping and identified frequent chromosomal breakpoints in 10p11, 14q11, and 14q32. Single nucleotide polymorphism (SNP) array-comparative genomic hybridization (CGH), genetic, and expression analyses of the genes mapped within a common breakpoint cluster region in 10p11.2 revealed that in ATLL cells, transcription factor 8 (TCF8) was frequently disrupted by several mechanisms, including mainly epigenetic dysregulation. TCF8 mutant mice frequently developed invasive CD4(+) T-cell lymphomas in the thymus or in ascitic fluid in vivo. Down-regulation of TCF8 expression in ATLL cells in vitro was associated with resistance to transforming growth factor beta1 (TGF-beta1), a well-known characteristic of ATLL cells, suggesting that escape from TGF-beta1-mediated growth inhibition is important in the pathogenesis of ATLL. These findings indicate that TCF8 has a tumor suppressor role in ATLL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467597     DOI: 10.1182/blood-2008-01-131185

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.

Authors:  Masaaki Watanabe; Shingo Nakahata; Makoto Hamasaki; Yusuke Saito; Yohei Kawano; Tomonori Hidaka; Kiyoshi Yamashita; Kazumi Umeki; Tomohiko Taki; Masafumi Taniwaki; Akihiko Okayama; Kazuhiro Morishita
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.

Authors:  Staci L Peters; Ryan A Hlady; Jana Opavska; David Klinkebiel; Slavomira Novakova; Lynette M Smith; Robert E Lewis; Adam R Karpf; Melanie A Simpson; Lizhao Wu; Rene Opavsky
Journal:  Mol Cell Biol       Date:  2013-09-03       Impact factor: 4.272

3.  FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.

Authors:  Natalina E Elliott; Susan M Cleveland; Victor Grann; John Janik; Thomas A Waldmann; Utpal P Davé
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

4.  Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.

Authors:  Baoqing Jia; Hongyi Liu; Qinglong Kong; Bing Li
Journal:  Mol Cell Biochem       Date:  2012-03-31       Impact factor: 3.396

5.  FISH Panel for Leukemic CTCL.

Authors:  Jason Weed; Juliet Gibson; Julia Lewis; Kacie Carlson; Francine Foss; Jaehyuk Choi; Peining Li; Michael Girardi
Journal:  J Invest Dermatol       Date:  2016-11-08       Impact factor: 8.551

6.  Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies.

Authors:  Liyanage P Perera; Meili Zhang; Masao Nakagawa; Michael N Petrus; Michiyuki Maeda; Marshall E Kadin; Thomas A Waldmann; Pin-Yu Perera
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

7.  New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.

Authors:  Ramon V Tiu; Lukasz P Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; Michael A McDevitt; Xiao Fei Wang; Mark J Levis; Judith E Karp; Anjali S Advani; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma.

Authors:  Jiaxing Zhang; Chenhui Lu; Jun Zhang; Jiuhong Kang; Chuanwu Cao; Maoquan Li
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

9.  Variegated RHOA mutations in adult T-cell leukemia/lymphoma.

Authors:  Yasunobu Nagata; Kenji Kontani; Terukazu Enami; Keisuke Kataoka; Ryohei Ishii; Yasushi Totoki; Tatsuki R Kataoka; Masahiro Hirata; Kazuhiro Aoki; Kazumi Nakano; Akira Kitanaka; Mamiko Sakata-Yanagimoto; Sachiko Egami; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Yusuke Shiozawa; Tetsuichi Yoshizato; Hiromichi Suzuki; Ayana Kon; Kenichi Yoshida; Yusuke Sato; Aiko Sato-Otsubo; Masashi Sanada; Wataru Munakata; Hiromi Nakamura; Natsuko Hama; Satoru Miyano; Osamu Nureki; Tatsuhiro Shibata; Hironori Haga; Kazuya Shimoda; Toshiaki Katada; Shigeru Chiba; Toshiki Watanabe; Seishi Ogawa
Journal:  Blood       Date:  2015-11-16       Impact factor: 22.113

10.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.